<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1850</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2023-31-4-651-657</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>THE MEDICAL REPRESENTATIVES, OR DEBATES OF 2010S ABOUT PROMOTION OF MEDICATIONS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vishlenkova</surname><given-names>E. A.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zatravkin</surname><given-names>S. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff id="aff-1">The Freiburg Institute for Advanced Studies, 79104, Freiburg, Germany</aff><aff id="aff-2"></aff><aff id="aff-3">N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia</aff><aff id="aff-4">The State Budget Institution “The Research Institute of Health Care Organization and Medical Management of the Moscow Health Care Department”, 115088, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2023-08-25" publication-format="electronic"><day>25</day><month>08</month><year>2023</year></pub-date><volume>31</volume><issue>4</issue><fpage>651</fpage><lpage>657</lpage><history><pub-date date-type="received" iso-8601-date="2025-07-03"><day>03</day><month>07</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2023,</copyright-statement><copyright-year>2023</copyright-year></permissions><abstract>The article considers the issue of the restrictions imposed by the government in the 2010s into process of introducing and promoting medications at the market by means of medical representatives. The government decided to formalize relationships of pharmaceutical manufacturers with consumers of medications. On the one hand, such a trend was occurring all over the world and was stimulated by social attacks at Big Pharma under slogan “the conflict of interests”. On the other hand, at the Russian pharmaceutical market, the restrictions of direct contacts of pharmaceutical manufacturers with physicians and and pharmaceutists were supported above all by national manufacturers of medicines. In the course of competition, vast army of Russian medical representatives was stigmatized that made many medics either to leave pharmaceutical market or to limit themselves to formal duties.</abstract><kwd-group xml:lang="en"><kwd>history of pharmacy</kwd><kwd>pharmaceutical market</kwd><kwd>the Post-Soviet Russia.</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>история фармации</kwd><kwd>фармацевтический рынок</kwd><kwd>постсоветская Россия.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Электронный ресурс: https://www.slideshare.net/Infor-media/schurov</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Давыдов С. А. A posteriori: полевые силы. Ремедиум. 2014;(6):32—7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Электронный ресурс: https://www.cossa.ru/149/99037/</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Электронный ресурс: http://archive.government.ru/special/docs/7859/</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Затравкин С. Н., Вишленкова Е. А., Игнатьев В. Г. Ренессанс российского фармрынка (2000—2004). Сообщение 2. Российские служители Фармы. Проблемы социальной гигиены, здравоохранения и истории медицины. 2023;(1):112—9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Электронный ресурс: http://www.medzapiski.ru/2013/01/cegedim-strategic-data.html</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Трищенко Д. А. Мифология лечения, ее спонсоры и протекторы. Знание. Понимание. Умение. 2018;(4):47—59.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Чупандина Е. Е., Дагир С. Обзор основных подходов и особенностей в продвижении лекарственных препаратов на российском рынке. Медицина и образование Сибири. 2015;(5):32—6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Широкова И. Бизнес адаптируется к новым регуляторным условиям. Ремедиум. 2012;(7):28—33.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Электронный ресурс: https://pharmvestnik.ru/content/articles/ljubovj-sizemova-tselj-zhizni-eto-zhiznj-s-tseljju.html</mixed-citation></ref></ref-list></back></article>
